Dimensional Fund Advisors LP Bio Xcel Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$6.39 - $28.58 $151,851 - $679,175	-23,764 Reduced 38.68%	37,668 $250,000
Q1 2023 May 12, 2023	SELL	$17.7 - $33.24 $139,617 - $262,197	-7,888 Reduced 11.38%	61,432 $1.15 Million
Q4 2022 Feb 09, 2023	SELL	$10.25 - $22.43 $51,547 - $112,800	-5,029 Reduced 6.76%	69,320 $1.49 Million
Q3 2022 Nov 10, 2022	SELL	$11.19 - $17.89 $924,640 - $1.48 Million	-82,631 Reduced 52.64%	74,349 $878,000
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $286,251 - $683,135	31,700 Added 25.3%	156,980 $2.07 Million
Q1 2022 May 13, 2022	BUY	$15.0 - $22.83 $1.44 Million - $2.2 Million	96,180 Added 330.52%	125,280 $2.62 Million
Q4 2021 Feb 09, 2022	BUY	$20.12 - $35.09 $585,492 - $1.02 Million	29,100 New	29,100 $592,000

3.06M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $83.5M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.